1. Home
  2. AERT vs EVAX Comparison

AERT vs EVAX Comparison

Compare AERT & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aeries Technology Inc.

AERT

Aeries Technology Inc.

HOLD

Current Price

$0.65

Market Cap

30.0M

ML Signal

HOLD

EVAX

Evaxion Biotech

HOLD

Current Price

$4.48

Market Cap

31.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AERT
EVAX
Founded
2012
2008
Country
Singapore
Denmark
Employees
1400
N/A
Industry
Professional Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
30.0M
31.9M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
AERT
EVAX
Price
$0.65
$4.48
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$11.67
AVG Volume (30 Days)
270.4K
31.1K
Earning Date
02-09-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$328.20
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.26
$1.44
52 Week High
$1.52
$12.15

Technical Indicators

Market Signals
Indicator
AERT
EVAX
Relative Strength Index (RSI) 64.41 57.45
Support Level $0.63 $3.98
Resistance Level $0.73 $4.62
Average True Range (ATR) 0.05 0.32
MACD -0.00 -0.00
Stochastic Oscillator 90.31 54.55

Price Performance

Historical Comparison
AERT
EVAX

About AERT Aeries Technology Inc.

Aeries Technology Inc is a professional and management services partner offering a range of management consultancy services for private equity sponsors and their portfolio companies with engagement models that are designed to provide a mix of deep vertical specialty, functional expertise, and digital systems and solutions to scale, optimize and transform a client's business operations. It supports and drives its client's growth across the globe by providing a range of management consultancy services involving professional advisory services and operations management services to build and manage dedicated delivery centers in appropriate locations based on customer business needs.

About EVAX Evaxion Biotech

Evaxion AS is a clinical-stage TechBio company developing novel vaccines with its proprietary, clinically validated and scalable AI platform, AI-Immunology. The platform harnesses the power of artificial intelligence to decode the human immune system and develop novel vaccine candidates for cancer and infectious diseases for patients in the market. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing inventive and targeted treatment options.

Share on Social Networks: